Skip to Main Content

Author Details

Catherine C Park
University of California san francisco
2000
53
30
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37335545Modifiable Postmastectomy Radiation Therapy Factors and Impact on Implant-Based Breast Reconstruction Outcomes.Plast Reconstr Surg2024
37478956American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics.Int J Radiat Oncol Biol Phys2024
37143943Dosimetric characterization of single- and dual-port temporary tissue expanders for postmastectomy radiotherapy using Monte Carlo methods.Front Oncol2023
34550601Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data.Cancer2022
35688516Seminars in Radiation Oncology-Breast Cancer.Semin Radiat Oncol2022
35777389Contralateral Disease Begets Contralateral Treatment.Int J Radiat Oncol Biol Phys2022
34153380Residents-as-Teachers Curriculum for Radiation Oncology: A Targeted Needs Assessment.Int J Radiat Oncol Biol Phys2021
28830795Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.Clin Breast Cancer2018
30190786xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction.Oncotarget2018
29126306The Future of Radiobiology.J Natl Cancer Inst2018
29296631Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL.J Med Imaging (Bellingham)2018
28973887Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.Proc Natl Acad Sci U S A2017
26714943Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.Ann Surg Oncol2016
26335703Dosimetric Comparison Between 3-Dimensional Conformal and Robotic SBRT Treatment Plans for Accelerated Partial Breast Radiotherapy.Technol Cancer Res Treat2016
26860947Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin.Breast Cancer Res Treat2016
25716473TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.Cancer Immunol Res2015
26337386Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors.Mol Biol Cell2015
26089220ACR Appropriateness Criteria® Ductal Carcinoma in Situ.Oncology (Williston Park)2015
25959051Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.Integr Biol (Camb)2015
25936815Rates of Reconstruction Failure in Patients Undergoing Immediate Reconstruction With Tissue Expanders and/or Implants and Postmastectomy Radiation Therapy.Int J Radiat Oncol Biol Phys2015
24246724Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary.Int J Radiat Oncol Biol Phys2014
25457912Postmastectomy radiotherapy in patients with breast cancer.Lancet2014
25375000The current clinical value of the DCIS Score.Oncology (Williston Park)2014
24584875Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?Breast Cancer Res Treat2014
24701707ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.Oncology (Williston Park)2014
24292868Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.Breast Cancer Res Treat2014
23576567NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells.Cancer Res2013
23883667β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.Breast Cancer Res2013
23667451MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy.PLoS One2013
23644530β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.Cancer Res2013
23812769Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer.Ann Surg Oncol2013
23407655Rapid and automated multidimensional fluorescence microscopy profiling of 3D human breast cultures.Integr Biol (Camb)2013
22929235Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure.Plast Reconstr Surg2012
21416100Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI.Integr Biol (Camb)2011
21884573β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.Breast Cancer Res2011
19395189Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation.Int J Radiat Oncol Biol Phys2010
20516121Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.Cancer Res2010
20206016American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.Int J Radiat Oncol Biol Phys2010
19701706HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment.Breast Cancer Res Treat2010
18692323High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer.Int J Radiat Oncol Biol Phys2009
19895268beta1 integrin targeting to enhance radiation therapy.Int J Radiat Biol2009
18519702Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.Cancer Res2008
18492917Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.AJR Am J Roentgenol2008
17234776Increased beta1 integrin is associated with decreased survival in invasive breast cancer.Cancer Res2007
18058364beta1 integrin as a molecular therapeutic target.Int J Radiat Biol2007
16452209Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.Cancer Res2006
15667984A comparison of Monte Carlo and Fermi-Eyges-Hogstrom estimates of heart and lung dose from breast electron boost treatment.Int J Radiat Oncol Biol Phys2005
16327765Radiation and the microenvironment - tumorigenesis and therapy.Nat Rev Cancer2005
15647075Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment.Breast J2005
12960393Ionizing radiation induces heritable disruption of epithelial cell interactions.Proc Natl Acad Sci U S A2003
  • 1 - 50 of 53

Recommended Authors

Duke University Medical Center
Career Start Year 2011
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
University of Milano
Career Start Year 2008
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 1
University of Virginia School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 1
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Division of Biostatistics and Clinical Trials, Mayo Clinic
Career Start Year 2003
Number of shared co-authors 3
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Weill Cornell School of Medicine
Career Start Year 1998
Number of shared co-authors 5
Clinica Universidad de Navarra, Cancer Center Universidad de Navarra
Career Start Year 1998
Number of shared co-authors 4
University of California
Career Start Year 1996
Number of shared co-authors 1
University of Groningen, University Medical Center Groningen
Career Start Year 1995
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 3
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 2
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 2
University Health Network
Career Start Year 1992
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 2
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 1
Queen Elizabeth University Hospital
Career Start Year 1986
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1985
Number of shared co-authors 4
University of Toronto, University Health Network
Career Start Year 1984
Number of shared co-authors 1
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1976
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1976
Number of shared co-authors 6

Collaborators

Oregon Health and Science University
Co-authored papers 3
12224University of California san francisco
Co-authored papers 3
Hamadan University of Medical Sciences
Co-authored papers 2
NASA Ames Research Center
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of Toronto
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California San Francisco (UCSF)
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 1
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
VIB-Center for Cancer Biology
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Duke University
Co-authored papers 1
Helen Diller Comprehensive Cancer Center, University of California san francisco
Co-authored papers 1
California Pacific Medical Center Research Institute
Co-authored papers 1
University of California at San Francisco
Co-authored papers 1
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Co-authored papers 1
Weill Cornell Medical College
Co-authored papers 1
Co-authored papers 1
University of California-Los Angeles
Co-authored papers 1